Diabetic Macular Edema: Faricimab Treatment Study

We are exploring whether Faricimab can improve vision in patients with diabetic macular edema. The study also examines changes in eye health and treatment frequency over 12 months.

>2 years ≤5 visits Monitoring phase (IV)No Placebo Standard Medicines InjectionEndocrinologyOphthalmology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Vabysmo

Vabysmo is an injected eye medicine used to treat vision loss from abnormal blood vessels in wet age-related macular degeneration and diabetic eye swelling.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Faricimab

Faricimab reduces abnormal blood vessel growth and leakage in the eye to help preserve vision in retinal vascular diseases.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Martin-Luther-Universitaet Halle-Wittenberg

Department of Ophthalmology, University Hospital Halle

Halle (Saale), Germany

Sponsor: Martin-Luther-Universitaet Halle-Wittenberg

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.